Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes

CSIR Recruitment 2020 For Biological Sciences at TKDL Unit – Apply Online

Enhancement of antiviral effectiveness against viral respiratory pathogens by engineering Fc domain of antibodies

CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes
  • BiotechToday
  • World

CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes

bioxone October 11, 2020October 10, 2020

-Surupa Chakraborty, Amity University Kolkata

A new CRISPR based test that can diagnose the coronavirus infection within few minutes, joins the race of speedy detection after RT-PCR, rapid testing, and FELUDA test. The potent applications of CRISPR have been talked about for many years now. It is best known for its ability to seek out and cut genetic material with unparalleled accuracy. Using this property, the researchers programmed CRISPR to search for specific genetic sequences found only in the SARS-CoV-2 virus.

The study published in the Science journal says that it is an inexpensive diagnostic test that could potentially detect the trace of the viral infection within 5 minutes using minimal lab equipment. Previously developed CRISPR based tests by the team, worked by identifying a 20 base long RNA sequence unique to SARS-CoV-2. The scientists created a ‘guide’ RNA complementary to the target RNA sequence which can bind together in the test solution. This in turn activates the CRISPR/Cas 13 ‘molecular scissors’ which cuts apart any single-stranded RNAs present nearby. These cuts generate fluorescent particles in the solution which emit fluorescent signals when hit by a laser beam. But this required the researchers to first amplify the viral RNA present in the sample, to increase the chances of spotting the signal, thereby, adding to its complexity, time, and cost of the diagnosis.

However, the recently developed novel CRISPR-based diagnostic test is based on multiple guide RNAs that work in unison to increase the sensitivity of the test, without the need of amplifying the viral RNA. The test was developed by a team of researchers, led by Jennifer Doudna, a recipient of the Nobel Prize in Chemistry, 2020, for her co-discovery of CRISPR. The test detected as few as 100,000 viruses per microliter of the solution with a single guide RNA, and 100 viruses per microliter with an additional guide RNA. Among samples taken from Covid-19 patients, it was able to precisely identify a batch of five positive samples within 5 minutes per test.

Also, this test is rendered beneficial in quantifying the viral load in the patients, which can help the doctors in their treatment procedures. A mobile phone-based device can be used to directly interpret the results of the diagnosis, which makes the entire assay portable, compared to bulky lab-based plate readers. Combined with efficient contact tracing, this CRISPR based SARS-CoV-2 easy detection test can thus play a pivotal role in the control of the current pandemic.

Source:

Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone. Parinaz Fozouni, Katherine S. Pollard, Joseph L. DeRisi, Jennifer A. Doudna, Daniel A. Melanie Ott, et al., (2020), medRxiv, https://doi.org/10.1101/2020.09.28.20201947

Also read: Soil Microbes Consume Atmospheric Hydrogen

For more articles, visit bioxone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged clinical trials COVID-19 CRISPR/Cas13a crRNAs direct detection assay pandemic quantification rapid testing SARS-CoV-2 screening

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • India
  • World

Enhancement of antiviral effectiveness against viral respiratory pathogens by engineering Fc domain of antibodies

bioxone October 11, 2020

-Richismita Hazra, Amity University Kolkata Antibodies serve as analytical barriers to viruses or viral infections. They play a dual role in communicating the existence of invading pathogens in infected cells, also, in interfering with the processes that are essential to the viral lifecycle. The antibodies activate phagocytes which is a potential mechanism of eradiating viruses. […]

Related Post

  • BiotechToday
  • World

Drug development from traditional to recent methods

bioxone June 7, 2021June 7, 2021

Varuni Ankolekar, Clinical Data Manager Traditionally, the discovery of drugs was done by recognizing the active ingredients from traditional remedies or unexpectedly.  Later, Scientists discovered that the interaction of specific chemicals in the drug with biological molecules of the human body serves the purpose of the drug. Later, Chemical pharmacological approaches were made to identify […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • Latest
  • World

Will Skin Rash Patterns help us detect COVID-19 infection faster and better?

bioxone September 11, 2020September 11, 2020

-Raddur Samaddar, Team bioXone COVID-19, since its outbreak showed plenty of symptoms. Being a strain of SARS, which is still very raw and new for complete scientific understanding most of the healthcare and research community primarily focused on the Pulmonary Symptoms and their specific modes of exhibition. Recent observation, that correlates with the studies conducted […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Can SARS-Cov-2 be neutralized potently, using engineered ACE2 receptor traps?

bioxone October 24, 2020October 24, 2020

Ayooshi Mitra, Amity University, Kolkata The crucial mechanism for severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and severe acute respiratory syndrome coronavirus 2  (SARS-CoV-2) infections initializes with the binding of the viral spike protein to angiotensin-converting enzyme II (ACE2) human receptor protein. In order to create a set of ACE2 variants optimized for affinity and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy